Showing results (81-90 of 154) with videos related to
Sort By:
Pageof 16
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|December 13, 2016
[Clinical and ultrasound assessment of the disease activity in patients with rheumatoid arthritis]Bożena Targońska-Stępniak, Mariusz Piotrowski, Robert Zwolak, et al.Wiadomosci Lekarskie (Warsaw, Poland : 1960)|July 5, 2005
[Ultrasonographic evaluation of kidneys in type-2 diabetes patients without overt nephropathy and with chronic renal failure]Maria Majdan, Maria Kurowska, Grazyna Orłowska-Kowalik, et al.Postepy Dermatologii I Alergologii|July 17, 2018
Overlap syndromes in systemic sclerosisEwa Wielosz, Maria Majdan, Magdalena Dryglewska, et al.Clinical Rheumatology|December 13, 2018
Diastolic dysfunction in rheumatoid arthritis patients with low disease activityBożena Targońska-Stępniak, Małgorzata Biskup, Wojciech Biskup, et al.Polish Archives of Internal Medicine|June 7, 2019
IRF5 promoter methylation as a new potential marker of rheumatoid arthritisMarek Cieśla, Bogdan Kolarz, Maria Majdan, et al.Polskie Archiwum Medycyny Wewnetrznej|August 23, 2012
Prevalence of antiphospholipid antibodies in rheumatoid arthritis patients and relationship with disease activityRadosław Jeleniewicz, Maria Majdan, Bożena Targońska-Stępniak, et al.Rheumatology International|May 19, 2018
Cardiovascular system changes in rheumatoid arthritis patients with continued low disease activityMałgorzata Biskup, Wojciech Biskup, Maria Majdan, et al.International Journal of Inflammation|April 16, 2020
Methylation Pattern of the SOCS3 and IL6R Promoters in Rheumatoid ArthritisMarek Cieśla, Bogdan Kolarz, Maria Majdan, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 17, 2014
Antiphospholipid antibodies during 6-month treatment with infliximab: a preliminary reportBogdan Kolarz, Maria Majdan, Dorota A Darmochwal-Kolarz, et al.Central-European Journal of Immunology|September 2, 2017
Influence of antiphospholipid antibody positivity on glomerular filtration rate markers in a group of systemic sclerosis patients - a 24-month observationEwa Wielosz, Maria Majdan, Arkadiusz Koszarny, et al.Pageof 16